https://curie.md/briefs/31254
FDA expands Winrevair label to cover recently diagnosed pulmonary arterial hypertension | Curie...
Sep 30, 2026 - The FDA has approved a label update for Winrevair (sotatercept) to include its benefit in adults recently diagnosed with pulmonary arterial hypertension (PAH)....
pulmonary arterialfdaexpandswinrevairlabel